$NICE Balance Sheet | Understand Stock

$NICE

$120.94 -$1.47 (1.2%) Live

$NICE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q4 FY2010 As of Dec 31, 2010
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Marketable securities
Short-term investments
Trade receivables (net of allowance for credit losses of $17,974 and $13,182 at December 31, 2025 and 2024, respectively)
Other receivables and prepaid expenses
Debt hedge option
Prepaid expenses and other current assets
Inventories
Current assets of discontinued operations
Total current assets

LONG-TERM ASSETS:
Marketable securities
Long-term investments
Other long-term assets
Prepaid expenses and other long-term assets
Property and equipment, net
Deferred tax assets
Operating lease right-of-use assets
Other intangible assets, net
Goodwill
Long-term assets of discontinued operations
Total long-term assets

Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables
Deferred revenues and advances from customers
Current maturities of operating leases liabilities
Debt
Accrued expenses and other liabilities
Current liabilities of discontinued operations
Total current liabilities

LONG-TERM LIABILITIES:
Deferred revenues and advances from customers
Accrued severance pay
Deferred tax liabilities
Debt
Operating leases
Other long-term liabilities
Long-term liabilities of discontinued operations
Total long-term liabilities

SHAREHOLDERS' EQUITY:
Authorized: 125,000,000 shares at December 31, 2025 and 2024; Issued: 74,774,827 shares at December 31, 2025 and 2024; Outstanding: 60,427,562 and 63,249,843 shares at December 31, 2025 and 2024, respectively
Additional paid-in capital
Treasury shares at cost – 11,904,158 and 11,139,836 Ordinary shares at December 31, 2023 and 2022, respectively
Treasury shares at cost – 14,347,265 and 11,524,984 Ordinary shares at December 31, 2025 and 2024, respectively
Accumulated other comprehensive loss
Retained earnings
Total attributable to NiCE Ltd.'s shareholders
Non-controlling interests
Total shareholders' equity
Total liabilities and shareholders' equity

Comments